South San Francisco, CA, United States of America

Wendy B Young

USPTO Granted Patents = 30 (Patent Applications = 7)

CIPO Patents = 7 (Patent Applications = 1)

EPO Patents = 15 (Patent Applications = 19)

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 235(Granted Patents)

Location History:

South San Francisco, CA (US) (2012 - 2013)
San Mateo, CA (US) (2000 - 2020)

Company Filing History:

Gilead Connecticut, Inc.

Axys Pharmaceuticals, Inc.

patents

7. 2 out of 168

F. Hoffmann-la Roche Ag

patents

where one patent can have more than one assignee

Years Active: 2000-2020

Loading Chart...

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE48239 - Heteroaryl pyridone and aza-pyridone compounds (2020-10-05),

2. 10344040 - Pyridone and aza-pyridone compounds and methods of use (2019-07-09),

3. 10053469 - Pyridone and aza-pyridone compounds and methods of use (2018-08-21),

4. 10045983 - Heteroaryl pyridone and aza-pyrodine compounds (2018-08-14),

5. 9782405 - Heteroaryl pyridone and aza-pyrodine compounds (2017-10-10),

6. 9505785 - Pyridone and aza-pyridone compounds and methods of use (2016-11-29),

7. 9326985 - Heteroaryl pyridone and aza-pyridone amide compounds (2016-05-03),

8. 9260415 - Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality (2016-02-16),

9. 9249123 - Pyridinones/pyrazinones, method of making, and method of use thereof (2016-02-02),

10. 9238655 - Heteroaryl pyridone and aza-pyridone compounds (2016-01-19),

11. 9162986 - [object Object] (2015-10-20),

12. 9115152 - Alkylated piperazine compounds (2015-08-25),

13. 8975260 - Pyridazinones, method of making, and method of use thereof (2015-03-10),

14. 8946213 - Alkylated piperazine compounds (2015-02-03),

15. 8921353 - Heteroaryl pyridone and aza-pyridone compounds (2014-12-30),

Title: Unveiling the Innovative Mind of Inventor Wendy B Young

Introduction: Wendy B Young, a prolific inventor hailing from South San Francisco, CA, has carved out a remarkable path in the field of pharmaceutical innovations. With an impressive portfolio of 30 patents to her name, Young's contributions have significantly impacted the realm of immune disorder treatments.

Latest Patents: Among Young's latest patents is the groundbreaking work on "Heteroaryl pyridone and aza-pyridone compounds," offering promising solutions for inhibiting Btk kinase and addressing immune disorders like inflammation. Her research delves into the methods of using these compounds for diagnosis and treatment in mammalian cells. Additionally, the "Pyridone and aza-pyridone compounds" patent underscores her dedication to advancing therapies for immune-related ailments.

Career Highlights: Wendy B Young has lent her expertise to renowned companies such as Genentech, Inc., and Gilead Connecticut, Inc. Her invaluable contributions have not only expanded the boundaries of pharmaceutical research but have also paved the way for innovative healthcare solutions. Young's passion for cutting-edge discoveries is evident in her patent portfolio, reflecting her commitment to improving patient outcomes.

Collaborations: Throughout her journey, Young has collaborated with esteemed professionals in the field, including Daniel Fred Ortwine and James John Crawford. These collaborative efforts have synergized diverse perspectives and expertise, fostering a culture of innovation and excellence in the pharmaceutical landscape.

Conclusion: In closing, Wendy B Young's indelible mark on the field of pharmaceutical innovations stands as a testament to her ingenuity and unwavering dedication. Her inventions continue to drive advancements in immune disorder treatments, offering hope for individuals grappling with such conditions. Young's exemplary career trajectory serves as an inspiration for aspiring inventors and underscores the profound impact of innovation in shaping a brighter future for healthcare.

This text is generated by artificial intelligence and may not be accurate.